News
0
Novartis has revealed new interim data from its Phase 3 trial investigating the efficacy of its gene therapy Zolgensma in the treatment of spinal...
0
-Gilead to lay off one fifth of sales force
-GSK to make redundancies at plant in Stevenage
-Genentech employee awarded $250,000 over racial...
0
NICE has announced its decision to recommend UCB Pharma’s Cimzia for use on the NHS in England in the treatment of severe plaque psoriasis in...
0
Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to research published...
Features
Spinnaker Opportunities announced in February it had reached a preliminary agreement to acquire cannabis oil-focused research firm Kanabo Research...
Featured Appointment
Insys Therapeutics has said Andrew Long will take over from Saeed Motahari as the company’s new CEO.
The opioid drugmaker said the decision...
Service Company News
Featured Event
25/09/2019 - 26/09/2019 -
London,
@Pharmafocus
